Human Molecular Genetics Advance Access originally published online on September 18, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2003, Vol. 12, No. 22 3007-3016
DOI: 10.1093/hmg/ddg316
© 2003 Oxford University Press
E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells
1Instituto de Patologia e Imunologia Molecular da Universidade do Porto (IPATIMUP), 4200-465 Porto,Portugal, 2Laboratory of Experimental Cancerology, Ghent University Hospital, B-9000 Ghent, Belgium, 3Department of Pathology and Laboratory Medicine, University of British Columbia Vancouver, Canada, 4Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, 4150-180, Porto, Portugal, 5Faculdade de Medicina, 4200-465 Porto, Portugal and 6Serviço de Anatomia Patológica, Hospital S. João,4200-465 Porto, Portugal
Received August 1, 2003; Revised August 22, 2003; Accepted September 10, 2003
In Hereditary Diffuse Gastric Cancer syndrome, E-cadherin germline mutations of the missense type harbour significant functional consequences. In this study, we have characterised the effect of T340A, A617T, A634V and V832M E-cadherin germline missense mutations on cell morphology, motility and proliferation. Wild-type E-cadherin and A617T expressing cells have an epithelial-like morphology, with polarised cells migrating unidirectionally. T340A and A634V expressing cells, fibroblast-like, have a high motile phenotype. We show that this phenotype is dependent on an increased level of active RhoA. V832M expressing cells grow in piled-up structure of round cells, as an effect of the disturbance of the binding between
-catenin and ß-catenin. The destabilisation of the adhesion complex is shown to hamper the motile capabilities of these cells. We did not observe any effect of the E-cadherin mutations on cell proliferation. We show the existence of a genotypephenotype correlation between different E-cadherin mutations and cell behaviour. However, we demonstrate that the ability of cells expressing the different E-cadherin mutations to invade is independent on their motile capabilities, providing evidence that motility is neither necessary nor sufficient for cells to invade. Our data give new insights into the understanding of the mechanisms linking invasion and E-cadherin mutations in diffuse gastric cancer.
* To whom correspondence should be addressed at: IPATIMUP, Rua Dr Roberto Frias s/n, 4200-465 Porto, Potugal. Tel: +351 225570764; Fax: +351 225570799; Email: rseruca{at}ipatimup.pt
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F Carneiro, C Oliveira, G Suriano, and R Seruca Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer J. Clin. Pathol., January 1, 2008; 61(1): 25 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Mateus, R. Seruca, J. C. Machado, G. Keller, M. J. Oliveira, G. Suriano, and B. Luber EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells Hum. Mol. Genet., July 1, 2007; 16(13): 1639 - 1647. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kaurah, A. MacMillan, N. Boyd, J. Senz, A. De Luca, N. Chun, G. Suriano, S. Zaor, L. Van Manen, C. Gilpin, et al. Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric Cancer JAMA, June 6, 2007; 297(21): 2360 - 2372. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Pereira, A. Teixeira, S. Pinho, P. Ferreira, J. Fernandes, C. Oliveira, R. Seruca, G. Suriano, and F. Casares E-cadherin missense mutations, associated with hereditary diffuse gastric cancer (HDGC) syndrome, display distinct invasive behaviors and genetic interactions with the Wnt and Notch pathways in Drosophila epithelia Hum. Mol. Genet., May 15, 2006; 15(10): 1704 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Oliveira, R. Seruca, and F. Carneiro Genetics, Pathology, and Clinics of Familial Gastric Cancer International Journal of Surgical Pathology, January 1, 2006; 14(1): 21 - 33. [Abstract] [PDF] |
||||



